Anish Suri - Net Worth and Insider Trading
Anish Suri Net Worth
The estimated net worth of Anish Suri is at least $231,941 dollars as of 2024-11-06. Anish Suri is the PRESIDENT AND CSO of Cue Biopharma Inc and owns about 135,638 shares of Cue Biopharma Inc (CUE) stock worth over $231,941. Details can be seen in Anish Suri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Anish Suri has not made any transactions after 2023-08-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Anish Suri
Anish Suri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Anish Suri owns 1 companies in total, including Cue Biopharma Inc (CUE) .
Click here to see the complete history of Anish Suri’s form 4 insider trades.
Insider Ownership Summary of Anish Suri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CUE | Cue Biopharma Inc | 2023-08-25 | President and CSO |
Anish Suri Latest Holdings Summary
Anish Suri currently owns a total of 1 stock. Anish Suri owns 135,638 shares of Cue Biopharma Inc (CUE) as of August 25, 2023, with a value of $231,941.
Latest Holdings of Anish Suri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CUE | Cue Biopharma Inc | 2023-08-25 | 135,638 | 1.71 | 231,941 |
Holding Weightings of Anish Suri
Anish Suri Form 4 Trading Tracker
According to the SEC Form 4 filings, Anish Suri has made a total of 6 transactions in Cue Biopharma Inc (CUE) over the past 5 years, including 1 buys and 5 sells. The most-recent trade in Cue Biopharma Inc is the acquisition of 4,000 shares on August 25, 2023, which cost Anish Suri around $11,040.
Insider Trading History of Anish Suri
- 1
Anish Suri Trading Performance
GuruFocus tracks the stock performance after each of Anish Suri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Anish Suri is 37.55%. GuruFocus also compares Anish Suri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Anish Suri within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Anish Suri's insider trading performs compared to the benchmark.
Performance of Anish Suri
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 3.2 | | | | | |
| Relative Return to S&P 500(%) | -1.29 | | | | | |
Anish Suri Ownership Network
Ownership Network List of Anish Suri
Ownership Network Relation of Anish Suri
Anish Suri Owned Company Details
What does Cue Biopharma Inc do?
Who are the key executives at Cue Biopharma Inc?
Anish Suri is the President and CSO of Cue Biopharma Inc. Other key executives at Cue Biopharma Inc include director & CEO Daniel R Passeri , Chief Medical Officer Matteo Levisetti , and Chief Business Officer Patricia Nasshorn .
Cue Biopharma Inc (CUE) Insider Trades Summary
Over the past 18 months, Anish Suri made 1 insider transaction in Cue Biopharma Inc (CUE) with a net purchase of 4,000. Other recent insider transactions involving Cue Biopharma Inc (CUE) include a net purchase of 3,000 shares made by Daniel R Passeri ,
In summary, during the past 3 months, insiders sold 0 shares of Cue Biopharma Inc (CUE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cue Biopharma Inc (CUE) were sold and 7,000 shares were bought by its insiders, resulting in a net purchase of 7,000 shares.
Cue Biopharma Inc (CUE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cue Biopharma Inc Insider Transactions
Anish Suri Mailing Address
Above is the net worth, insider trading, and ownership report for Anish Suri. You might contact Anish Suri via mailing address: 40 Guest Street, Boston Ma 02135.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
